Sanazole as a sensitizer of hypoxic cells with radical radiation in the treatment of advanced cancer of cervix an Indian experience

Indian Journal of Cancer

Volumn 39, Issue 2, 2002, Pages 39-44

  Huilgol, Nagraj G ^a   Dobrowsky, Werner ^b   Tatsuzaki, Hideo ^c   Chatterjee, Neela A ^a   Kagiya, V T ^d   Das, Kaushik ^e  

^a DR BALABHAI NANAVATI HOSPITAL   (India)

^b Sonderabteilung fur Strahlentherapie   (Austria)

^c INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

^d IIT ^*  (Japan)

^e INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

SENAZOLE; RADIOSENSITIZING AGENT; TRIAZOLE DERIVATIVE;

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENCY; DRUG SENSITIZATION; HUMAN; HYPOXIC CELL; NEUROPATHY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; UTERINE CERVIX CANCER; ADULT; AGED; FEMALE; INDIA; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEUROLOGIC DISEASE; SURVIVAL RATE; UTERINE CERVIX TUMOR;

ADULT; AGED; FEMALE; HUMANS; INDIA; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TRIAZOLES; UTERINE CERVICAL NEOPLASMS;

EID: 0037871945     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Dische S., Chassagne D., Hope-Stone H.F., et al: A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: an interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix. Radiotherapy and Oncology 1993: 26; 93-103.
2. th Edition Lippincot Company, The oxygen effects and reoxygenation 1994: 133-152.
3. Eschwege F., Sancho-Garnier H., Chassagne D., et al: Results of a European randomized trial of etamdazole combined with radiotherapy in head and neck carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 1997: 39; 275-281.
4. Garcia A., Peru: Tolerable oral dose of AK-2123 Radiosensitization Newsletter Vol.10, No.1; Jan. 1991.
5. Huilgol N.G., Nair C.K.K., Mathew R., Chatterjee N.A., and Singh B.B.: AK2123 with discontinuous accelerated hyperfractionated radiation in the treatment of head and neck cancer. Sensitization Newsletter-15 Vol. II No.2; pp 10-11; April 1997.
6. Huilgol N.G., Chatterjee N., Singh B.B. and Mehta A.R.: AK-2123 a hypoxic cell potentiator of radiation - A report on the use of AK-2123 in head and neck cancer. Journal of Clinical Radiotherapy Oncology 1995: 10(1); 9-10.
7. Huilgol N.G., Soni A. Chatterjee N., Nair C.K.K., Mathew R.: Case studies of intra-artierial administration of AK-2123 with embolisation in re-radiation of cancer of cervix.
8. Huilgol N.G., Chatterjee N.A. and Kagiya V.T.: Hypoxic cell sensitization with discontinuous accelerated radiation of head and neck cancer and theoretical basis for adjuvant hyperthermia. Jpn. J. Hyperthermic Oncol. 1998: 14 (Suppl); S-109-110.
9. Hockel M., Schlanger K., Aral B., Mitze M., Schaffer U., and Vaupel P.: Association between tumour hypoxia and malignant progression in advanced cancer of cervix. Cancer Research 1996: 56; 4509-15.
10. Imamura M., Edgren M.R., Murata T., Imamura M., Nagata K., Isoda H., Akagi K., Revesz L. and Tanaka Y.: Radiosensitization with a 3-nitrotriazole-AK-2123: Int. J. Oncology 1995: 6; 841-845.
11. Mathews R.: Studies on the mechanism of action of the radiosensitizer AK-2123 as an adjuvant to radiotherapy of cancer. Ph.D. thesis Bombay University, January 1999.
12. Mathew R., Rajagopalan R., Huilgol N.G., Nair C.K.K. and Singh B.B.: Clinical pharmacokinetics of the hypoxic cell radiosensitizer Sanazole (AK-2123) in cancer patients by intravenous administration. Presented at the XVIII Annual Conference of the Association of Clinical Biochemists of India December 1996 held at Kerla, India. Sensitization Newsletter Vol.4 No.2; B-5/10, 1997.
13. Morris M., Eifel P.J., Lu J. Grigsby P.W., Levenback C., Stevens R.E., Rotman M., Gershenson D.M., Mutch D.G.: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. The New England Journal of Medicine 1999: Vol. 340, No.15; 1137-1153.
14. Talaeva Sh.: Concurrent intravenous and intratumoural radiosensitization by AK-2123 in the radiotherapy of locally advanced breast carcinoma - Preliminary results. Sensitization Newsletter 1997: 4(4); 4-7.
15. th edition 1997: Wiley - Liss - A John Wiley & Sons, Inc. Publications.
16. Vaupel P., Kallinowski F., Okinieff P.: Blood flow, oxygen and nutrient supply and metabolic environment of human tumours. A review. Cancer Res. 1989: 49; 6449-6465.
17. Watson E.R., Halnan K.E., Dische S. et. al.: Hyperbaric oxygen and radiotherapy - a Medical Research Council trial in carcinoma of cervix. Br. J. of radiology 1978; S1: 879-87.